ArticleJournal of translational medicine2012

Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.

Zhi-Yuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.